Masimo W1™ Limited Market Release for Consumers
On May 2, 1989 a garage startup solved the “unsolvable” problem of inaccurate and unreliable pulse oximetry measurements during real-life conditions such as movement. That startup was Masimo, the inventor of Measure-through Motion and Low Perfusion™ SET® pulse oximetry.
As the first of its kind, the W1 continues Masimo’s legacy of innovation with accurate, continuous monitoring of multiple health parameters – including oxygen saturation (SpO2), pulse rate, perfusion index, PVi®, and respiration rate, alongside step count and fall detection. This personal, discreet, and lifestyle-friendly wearable is designed to offer actionable insight into your health.
Masimo will provide a limited number of W1s on a first-come, first-served basis, at a 50% discount, to users who agree to the program details and to provide feedback and data to Masimo.
Masimo will contact you at the email address you submit above. We will let you know whether you have been chosen to participate in the W1 Limited Market Release and details about your participation.
For more information about your privacy rights, please see Masimo’s General Privacy Notice. For California residents, please see our CA Privacy Notice.
Masimo W1 is not FDA cleared.